Compare Figma Inc. Class A Common Stock (FIG) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figma Inc. Class A Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Figma Inc. Class A Common Stock trades at $21.43 (market cap $11.60B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Figma Inc. Class A Common Stock and Dr. Reddy's Laboratories Ltd Common Stock are close in size by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Figma Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| FIG | RDY | |
|---|---|---|
Market Cap | $11.60B | $10.78B |
Volume | 12,281,013 | 2,724,343 |
Sector | Technology | Health |
52-Week High | $63.82 | $15.38 |
52-Week Low | $16.84 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.00B | $10.68B |
Dividend Yield | — | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Figma Inc. Class A Common Stock
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
